Diaverum continues to grow its international presence by acquiring the CTN clinic in São Paulo, Brazil

Diaverum, a leading global renal care service provider, continues to increase its renal care services in Brazil through the acquisition of CTN – Clínica de Nefrologia Ltda, a clinic based in Mauá, greater São Paulo.

The acquisition is another milestone for Diaverum in Brazil, which since entering the market in 2018, has expanded to provide life enhancing renal care at nine clinics, treating more than 3,200 patients across the country.

“This acquisition reinforces our presence in Brazil and our commitment to the renal patients and the healthcare system of the country. CTN is a strategic, high-standard treatment centre with professionals aligned with our mission to provide life-enhancing renal care to our patients. We warmly welcome them in Diaverum family.” comments Boris Zjacic, Chief Operating Officer, Diaverum.

“CTN adds another strategic cornerstone to our presence in the São Paulo area. We are very pleased to welcome a young, dynamic and inspired team with high quality standards to our family. We’ll work together to integrate CTN into our organization and apply our solid Contingency Plan to safeguard its operations throughout the COVID crisis," adds Rafael Romanini, Country Manager Brazil, Diaverum.

Brazil media contact:

Mr Rafael Ferreira, Communications, Diaverum Brazil

E-mail: Rafael.ferreira@diaverum.com

Contact: +55 11976494027

Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD). Diaverum is a leading global provider in renal care services, serving 39,500 patients with 6 million treatments annually. The company’s core service is haemodialysis but provides a broad portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to patient care coordination and transplantation services. Diaverum employs more than 12,000 employees and operates more than 400 clinics in 22 countries globally. Diaverum has its head office in Malmö, Sweden www.diaverum.com

About Us

Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe, and we help some 39,000 patients with 6 million treatments annually. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services. CKD is a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries. CKD disproportionately affects low income individuals and we ensure that our clinics are a safe and familiar space where all our patients are made to feel welcome. Diaverum’s vision is to transform renal care, to offer the highest quality of care and empower patients to live a fulfilling life. We work together with payers to reduce total cost of care while partnering with local communities to educate around health and the value of prevention. At the centre of what we do is our standardised, proprietary care delivery model, enabled by a continuously evolving digital infrastructure. We strive to ensure superior medical outcomes exceeding those demanded by national healthcare systems and we support patients by improving personalized care, ease of use and new services through technology. Diaverum employs more than 11,000 employees and operates more than 400 clinics in 22 countries globally. Diaverum has its head office in Malmö, Sweden.

Subscribe

Media

Media